ESR1 and breast carcinoma: This study will have significant clinical implications in selecting the type of chemotherapy in breast cancer patients at pre- and post-menopausal age, and potential of estrogen-pretreatment followed by chemotherapy in post-menopausal breast cancer patients with estrogen receptor-positive tumors.